top of page
Alveron Pharma is developing a unique coagulation
platform technology with the world's first
cyclodextrin-based anticoagulant reversal drug
Contact
bottom of page
Alveron Pharma is developing a unique coagulation
platform technology with the world's first
cyclodextrin-based anticoagulant reversal drug